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Objective: Abdominal aortic coarctation is uncommon and often complicated with coexisting splanchnic and renal artery
occlusive disease. This study was undertaken to define the clinical and anatomic characteristics of this entity, as well as the
technical issues and outcomes of its operative treatment.
Methods: Fifty-three patients, 34 males and 19 females, underwent surgical treatment of abdominal aortic coarctations
from 1963-2008 at the University of Michigan. Patient ages in years ranged from 2-4 (n  4), 5-8 (n  17), 9-14 (n 
16), 15-20 (n  11) and 25-49 (n  5). The mean age was 11.9 years. Developmental disease (n  48), inflammatory
aortitis (n  4), and iatrogenic trauma (n  1) were suspected etiologies. Aortic coarctations were suprarenal (n  37),
intrarenal (n  12), or infrarenal (n  4). Patients often had coexisting occlusive disease of the splanchnic (n  33) and
renal (n  46) arteries.
Results: Major clinical manifestations included: aortic and renal artery-related secondary hypertension (n  50),
symptomatic lower extremity ischemia (n  3), and intestinal angina (n  3). Primary aortic reconstructive procedures
included: thoracoabdominal bypass (n  26), patch aortoplasty (n  24), or an aortoaortic interposition graft (n  3).
Primary splanchnic (n 19) or renal (n 47) arterial reconstructions were performed as simultaneous (n 45) or staged
(n  13) procedures in relation to the aortic surgery. Benefits existed regarding improved control of hypertension (n 
46), as well as elimination of extremity ischemia (n  3) and mesenteric angina (n  3). Secondary renal or splanchnic
arterial reoperations (n  8) were performed without mortality 5 days to 12 years postoperative for failed primary
procedures. Secondary aortic procedures, 5 to 14 years postoperative, were performed for patch aortoplasties that became
stenotic (n  2) or aneurysmal (n  1), and when thoracoabdominal bypasses developed an anastomotic narrowing
(n  1) or proved inadequate in size with patient growth (n  1). No perioperative mortality accompanied either the
primary or secondary aortic reconstructive procedures.
Conclusion: Abdominal aortic coarctation represents a complex vascular disease. Individualized treatment changed little
over the period of study, remaining dependent on the pattern of anatomic lesions, patient age, and anticipated growth
potential. This experience documented salutary outcomes exceeding 90% following carefully performed operative
therapy. (J Vasc Surg 2008;48:1073-82.)Coarctation of the abdominal aorta is a rare disease
encompassing many differing etiologies and diverse meth-
ods of treatment.1-20 The impetus for this report was to
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doi:10.1016/j.jvs.2008.05.078better define the anatomic and clinical character of this
entity, as well as the technical issues and adequacy of
conventional open vascular reconstructive procedures in
treating a broad spectrum of abdominal aortic coarctation.
Benefits of surgical repair were assessed with an emphasis
on long-term follow-up.
METHODS
Patient characteristics. Fifty-three patients with ab-
dominal aortic coarctation underwent operative treatment
at the University ofMichiganMedical Center from 1963 to
2008. The series included 34 male and 19 female patients,
ranging in age from 2 to 49 years, with a mean age of 11.9
years. Patient ages in years were: 2-4 (n 4), 5-8 (n 17),
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patients outnumbered females 24:13 under age 15 years
and 10:6 over 15 years.
Two earlier publications from this institution in 1979
and 1981 included 10 of the current series’ patients.8,16
Two additional publications, one on pediatric splanchnic
arterial disease in 2002, and another on pediatric renovas-
cular hypertension in 2006, briefly referred to this entity in
children.21,22 The current report evolved from a retrospec-
tive review of existing medical records, direct communica-
tions with the patients or their families, as well as referring
physicians. Statistical analysis of anatomic differences, pa-
tient demographics, and treatment variations compared to
outcomes were undertaken. This study was approved by the
University of Michigan Medical School Institutional Re-
view Board (HUM 00006223).
Etiology. Developmental coarctations were suspected
in the majority (n  48) of this series’ patients. A develop-
mental etiology received support in the confirmed coexist-
ence of neurofibromatosis-1 (NF-1) in 14 patients, an
excessive number of multiple renal arteries in 16 of the 37
patients with suprarenal narrowings, Williams Syndrome in
1 patient, and Alagille syndrome in another patient. Certain
Fig 1. A, Suprarenal abdominal aortic coarctation (bra
bilateral renal artery ostial stenoses (arrows). Note co
computed tomographic angiography (CTA) (anterior andevelopmental aortic narrowings may have evolved from aquiescent aorto-arteritis, yet no discernable evidence ex-
isted to confirm such a diagnosis. Nevertheless, others
exhibited atypical abdominal aortic coarctations having the
characteristics of an inflammatory aortitis (n  4). Balloon
angioplasty of a thoracic aortic coarctation in a newborn at
another hospital, complicated by aortic thrombosis, was
considered the cause of an intrarenal coarctation (n 1) in
the series remaining patient.
Aortic disease. Extensive preoperative imaging of the
aorta, the celiac artery (CA), superior mesenteric artery
(SMA), and renal arteries was undertaken in all patients
(Figs 1, 2 and 3). Imaging during the earlier years of this
experience involved catheter-based aortography. Magnetic
resonance angiography (MRA) subsequently became a
common diagnostic test, but conventional arteriography
was often necessary to confirm the hemodynamic impor-
tance of aortic branch stenoses. Thin-cut computed tomo-
graphic arteriography (CTA) has improved the anatomic
characterization of many complex lesions, and is currently
the single most frequently used preoperative study.
Suprarenal abdominal aortic coarctations (n  37),
beginning above the celiac artery or superior mesenteric
artery included 5 patients with diffuse aortic hypoplasia,
with superior mesenteric artery stenosis (arrow) and (B)
n trunk of lower lumbar artery (arrow). Preoperative
sterior projections, respectively).cket)
mmoextending three times from the mid thoracic aorta to the
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dominal aorta to below the inferior mesenteric artery. In
the later cases, the narrowing was most severe in the upper
abdominal aorta. Among suprarenal coarctations, all but
four exhibited renal or splanchnic arterial stenoses or oc-
Fig 2. Intrarenal abdominal aortic coarctation with bilateral ar-
tery stenoses (arrows). Preoperative aortogram.
Fig 3. Infrarenal abdominal aortic coarctation with an associated
spontaneous pseudoaneurysm (arrow). Preoperative aortogram.clusions. Intrarenal coarctations (n  12), beginningabove the renal arteries, but below the SMA, were all
associated with renal artery disease. Infrarenal coarctations
(n  4), beginning below the renal arteries were focal in
one case, presented as long tubular narrowings twice, and
were associated with a terminal aortic occlusion once. Two
of the four infrarenal coarctations exhibited renal artery
stenoses.
Aortic branch disease. Renal artery stenoses affected
46 patients, being most often ostial (n  44) and bilateral
(n 41). Aneurysms affected the proximal renal artery in 3
patients and the distal renal artery in 1 patient. Multiple
renal arteries accompanied 43% of the suprarenal abdomi-
nal aortic coarctations. Splanchnic arterial disease included
CA and SMA ostial stenoses or occlusions (n 33), involv-
ing both vessels in all but 6 patients, as well as a CA
aneurysm (n  1) and common celiaco-mesenteric trunks
(n  4) of which one was aneurysmal.
Clinical manifestations. Refractory hypertension was
the major clinical manifestation, affecting 50 patients,
whose mean preoperative blood pressures were 164/112
mm Hg while on antihypertensive medications. Appropri-
ate published standards for normal blood pressure were
used in the pediatric-aged patients.23 Hypertension was
classified as cured if the patient was taking no antihyperten-
sive medications and they were normotensive for the pre-
ceding 6months; improved if they were normotensive while
on drug therapy exclusive of angiotensin-converting en-
zyme (ACE) inhibitors, or if their diastolic pressure was
higher than normal but 15% lower than preoperative levels;
and failures if the diastolic pressure was higher than the
normal and not 15% lower than preoperative levels or if
ACE inhibitors were required for blood pressure control.
Three patients experienced intestinal angina with
weight loss. Three additional patients described ischemia-
related lower extremity fatigue with ambulation and had
abnormal ankle-brachial indices that declined following
treadmill exercise.
RESULTS
Surgical treatment. Aortic reconstructions included
thoracoabdominal bypasses, patch aortoplasties, and inter-
position aortoaortic grafts. No major therapeutic changes
occurred over the decades of practice, with specific inter-
ventions being dependent on the patient’s age, and the
pattern of the aortic disease as well as the associated renal
and splanchnic arterial disease (Table I). Statistical analyses
did not find a correlation between the patient’s age, aortic
anatomy, and treatment type, to the outcome of survival or
improvement in the patient’s clinical status.
Thoracoabdominal bypass grafts (n  26) originated
from the distal thoracic aorta above the diaphragm or from
the supraceliac aorta at the diaphragmatic hiatus, being
passed behind the left kidney to the distal aorta (Fig 4). In
most older patients, aortic exposure was facilitated by a
thoracoabdominal incision through the left sixth or seventh
intercostal space extending from the posterior axillary line
across the costal margin, onto the abdomen, in either an
oblique fashion to the right of the umbilicus or as a midline
Staged – Procedure performed either before* or after† aortic reconstruction.
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November 20081076 Stanley et alFig 4. A, Suprarenal coarctation (bracket) with superior mesenteric artery stenosis (arrow). Preoperative magnetic
resonance angiography (MRA). B, Thoracoabdominal bypass (broad arrow) with aortic implantation of superiorTable I. Patterns of aortic and aortic branch reconstructive procedures
Aortic Coarctation
Suprarenal
(n  37)
Intrarenal
(n  12)
Infrarenal
(n  4)
Patch aortoplasty (n  24)
Concomitant renal procedure 14 7 1
Concomitant splanchnic procedure 10 1 0
Staged renal procedure 4* 4*, 1
†
0
Staged splanchnic procedure 1 1
†
0
No renal or splanchnic procedure 1 0 0
Thoracoabdominal bypass graft (n  26)
Concomitant renal procedure 17 3 0
Concomitant splanchnic procedure 14 1 0
Staged renal procedure 1*, 2
†
0 0
Staged splanchnic procedure 0 0 0
No renal or splanchnic procedure 4 0 1
Interposition aortic graft (n  3)
Concomitant renal procedure 0 1 1
Concomitant splanchnic procedure 0 0 1
Staged renal procedure 0 1* 0
Staged splanchnic procedure 0 1
†
0
No renal or splanchnic procedure 0 0 1
Renal Procedure – Number of primary unilateral or bilateral renal artery reconstructive procedures.
Splanchnic Procedure – Number of primary celiac, superior mesenteric, or combined celiac and superior mesenteric arterial reconstructive procedures.
Concomitant – Procedure performed at the same time of aortic reconstruction.mesenteric artery (arrow). Postoperative computed tomographic angiography (CTA).
n. Po
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adolescents, a transverse supraumbilical abdominal incision
was used most often, extending laterally to the posterior
axillary lines, combined with medial rotation of the viscera,
allowing access to the abdominal aorta from its supraceliac
level at the aortic hiatus to the origin of the iliac arteries.
Dacron graft knitted or woven thoracoabdominal
grafts (n  9) were used in the earlier experience, with
expanded Teflon grafts (n 17) used more often in recent
years because of their greater stability regarding postim-
plantation dilatation. Graft diameter was chosen to be as
big as possible, short of being so large that excessive luminal
thrombus would accumulate. In children, the intent was
always to oversize grafts compared to the aorta, with antic-
ipated growth otherwise resulting in a graft too small to
maintain normal distal pressures and flow. In the ideal
circumstance, one should use a graft whose size would not
represent an energy-consuming constriction as the patient
grows into maturity. This means having a conduit at least
60% or 70% the size of the adult aorta. This translates into
using 8-12 mm grafts in young children, 12-16 mm grafts
for early adolescents, and 14-20 mm grafts in late adoles-
cents and adults. In the very young child, use of large
conduits may not be possible. Graft length was a non-issue
in older children and adolescents, with axial growth from
the diaphragm to pelvis being minimal after age 9 or 10 in
Fig 5. A, Suprarenal coarctation (bracket) with bilater
aortoplasty (broad arrow) with aortic diameter exceeding
of the renal arteries accompanied the aortic reconstructiolate childhood.Patch aortoplasty (n  24) was usually undertaken
when the coarctation segment had a large enough diameter
to allow completion of an anastomosis without an overlap
of sutures from the opposing sides of the patch (Fig 5).
Whenever possible, patches in children were made suffi-
ciently large enough, similar to thoracoabdominal graft
sizing, so as to not be constrictive with growth into adult-
hood, yet not so generous as to risk development of an
extensive lining of unstable thrombus. Teflon graft material
was again favored over Dacron graft, because of the latter’s
propensity for dilatation years after implantation.
Interposition aortoaortic grafts (n  3) were used in
treating one suprarenal and two infrarenal coarctations.
The latter were placed using surgical techniques similar to
those used in aortic aneurysm surgery. Exposure was
through the retroperitoneum at the root of the mesocolon
and small bowel mesentery, from the level of the left renal
vein to the aortic bifurcation.
Primary renal and splanchnic arterial reconstructions
were performed as simultaneous (n  45) or staged (n 
13) procedures in relation to the patient’s aortic surgery.
When simultaneous reconstructions were performed, they
usually were done following completion of the aortoplasty
or aortic bypass. Among the staged operations, nine were
prior to the aortic reconstruction, and four occurred after
the aortic procedure. These nonaortic reconstructions in-
al artery ostial stenoses. Preoperative MRA. B, Patch
of uninvolved proximal and distal aorta. Reimplantation
stoperative computed tomographic angiography (CTA).al ren
thatcluded direct aortic implantations of the normal renal or
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well as internal iliac aorto-visceral bypasses. Implantation of
these arteries into a synthetic conduit or patch is not
recommended because of the greater potential for later
anastomotic narrowing. Four patients underwent a ne-
phrectomy for unreconstructable renal artery disease, twice
before the aortic procedure and two times at the time of the
aortic reconstruction. These procedures were the topic of
earlier publications by the authors.21,22,24
Operative outcomes. No perioperative mortality fol-
lowed the primary aortic or combined aortic and visceral
arterial reconstructive procedures. Similarly, there were no
ischemic intestinal complications or patients having post-
operative renal insufficiency requiring dialysis. One patient
with Moya Moya syndrome incurred a perioperative stroke
and made a satisfactory recovery.
Early reoperations were performed without sequelae
for nonaortic-related complications, including intra-
abdominal bleeding (n 2), and a renal artery anastomotic
pseudoaneurysm (n  1). Life table analysis documented
excellent aortic graft patencies (Table II). Late reoperative
aortic surgery occurred in 2 patients having thoracoab-
dominal bypasses. One outgrew the original graft and had a
replacement graft 7 years postoperatively, and the other
underwent revision of a proximal anastomotic stenosis 9
years postoperatively. Three patients with patch aortoplas-
ties had late reoperations. Two with patches that proved
inadequate in size with growth underwent thoracoabdomi-
nal bypasses, performed 5 and 10 years after their initial
aortic procedure. The third patch failure, aneurysmal dete-
rioration of the aorta at the site of the aortoplasty, occurred
14 years postoperatively and was treated with placement of
an interposition aorto-aortic graft.
Reoperations were anticipated in the 3 children who
outgrew their original aortic reconstructions performed at
Table II. Life table analysis of aortic graft patency over tim
Interval
(years)
Grafts at
risk
Graft
failure
Grafts with incom
follow-up for int
0 1 53 0 7
1 2 46 0 5
2 3 41 0 2
3 4 39 1 9
4 5 29 0 6
5 6 23 0 1
6 7 22 0 2
7 8 20 1 2
8 9 17 0 5
9 10 12 1 0
10 11 11 1 2
11 12 8 0 1
12 13 7 0 1
13 14 6 0 2
14 15 4 1 0
15 16 3 0 1
20 21 2 0 1
46 47 1 0 1ages 5, 6, and 8 years. The initial aortic procedure wasconsidered essential for the child’s health, could not be
deferred to an older age, and could not safely have encom-
passed an initial aortic repair of greater dimensions. No
perioperative mortality or major complications accompa-
nied the aortic reoperations.
Thirty-nine of this series’ patients had patent and satis-
factory function of their visceral artery reconstructions (63
renal and 16 splanchnic individual revascularizations) at the
latest time these vessels were imaged, averaging 5.4 years
postoperative. Nine patients, including 4 of the former
individuals and 5 additional patients experienced failed
visceral artery reconstructions (10 renal and 3 splanchnic
revascularizations). These reconstructive failures included
aneurysmal deterioration of four aortorenal bypass grafts,
which are not used in contemporary practice. Eight patients
with failed visceral reconstructions underwent successful
reoperations 5 days to 12 years postoperatively, without
mortality. The remaining patient’s failed visceral recon-
struction did not require reoperation. Life table analysis of
renal and splanchnic procedures revealed excellent paten-
cies (Table III).
Benefits of surgical therapy were reflected in cured (n
28) or improved (n  18) hypertension in 46 of the 53
patients. Their mean postoperative pressure was 121/72
mm Hg at the most recent time of follow-up. This repre-
sented a significant decrease compared to the mean preop-
erative pressure (P  .01). Four patients had no change in
their hypertensive state. All were subjected to repeated
operations, including two with secondary intraluminal
stent placement (one aortic and one renal artery). The 3
patients with symptomatic lower extremity ischemia expe-
rienced complete relief following surgery. The 3 patients
with intestinal angina had resolution of their postprandial
abdominal pain and all had rapid weight gain.
Six patients died late in follow-up, with none directly
53 patients with mid abdominal aortic coarctation
Overall graft
patency
Standard
error
[95% Confidence
intervals]
1.0000 0.0000 * *
1.0000 0.0000 * *
1.0000 0.0000 * *
0.9710 0.0286 0.8115 0.9959
0.9710 0.0286 0.8115 0.9959
0.9710 0.0286 0.8115 0.9959
0.9710 0.0286 0.8115 0.9959
0.9199 0.0566 0.7017 0.9805
0.9199 0.0566 0.7017 0.9805
0.8432 0.0899 0.5595 0.9512
0.7589 0.1138 0.4492 0.9093
0.7589 0.1138 0.4492 0.9093
0.7589 0.1138 0.4492 0.9093
0.7589 0.1138 0.4492 0.9093
0.5692 0.1851 0.1743 0.8338
0.5692 0.1851 0.1743 0.8338
0.5692 0.1851 0.1743 0.8338
0.5692 0.1851 0.1743 0.8338e in
plete
ervalrelated to the patient’s aortic disease or surgery. These
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occurred 9 to 26 years postoperatively, and were due to
trauma (n 2), cancer (n 2), stroke (n 1) andmyocardial
infarction (n 1). Follow-up averaged 5.9 years. Contempo-
rary follow-up was complete in all but 4 of the 47 surviving
patients. The patients’ clinical status in the case of those
individuals residing at long distances from the authors’ hospi-
tal was obtained by direct contact with the referring physician.
Forty-one of the series’ 53 patients have been treated since
1994.
DISCUSSION
Abdominal aortic coarctation is uncommon and, as
evident in the present series, is often associated with coex-
isting splanchnic and renal artery occlusive disease. Differ-
ences in the reported clinical relevance of abdominal aortic
coarctations usually reflect differences in the etiology of
coarctations being treated at a given institution.
Aortic coarctation character. An earlier collective re-
view of 119 cases identified suprarenal coarctations in 11%,
intrarenal coarctations in 54%, infrarenal coarctations in
25%, and diffuse aortic hypoplasia in 12%.8 Differences in
the current series, with 69% suprarenal, 23% intrarenal, and
8% infrarenal, reflect a more contemporary classification of
aortic coarctation, based upon the most superior level of
the narrowing. Indeed, it is the most cephalic extent of the
disease that defines the complexity of the aortic reconstruc-
tion, with considerable differences if the CA and SMA are
involved, compared to the renal arteries alone. Most aortic
coarctations are diminutive vessels, often with an hour-glass
narrowing representing a lack of growth in developmental
lesions or contraction in cases of an inflammatory aortitis.
Associated renal and splanchnic arterial disease.
Nearly 80% of patients with abdominal aortic developmen-
tal lesions have been reported to have renal artery stenoses,8
a finding consistent with the present series in which 87%
Table III. I. Life table analysis of reconstructive patency o
procedures in patients with mid abdominal aortic coarctati
Interval
(years)
Reconstructions
at risk
Reconstructive
failure
Reconstru
incomple
for in
0 1 92 2
1 2 81 0
2 3 74 7
3 4 57 0
4 5 40 2
6 7 33 0
7 8 30 0
8 9 28 0
10 11 13 1
11 12 10 0
12 13 7 1
14 15 6 0
18 19 3 0
24 25 2 0
44 45 1 0had renal artery narrowings or occlusions. Splanchnic arte-rial occlusive disease has been previously reported to affect
22% of patients with abdominal aortic coarctations.8 The
true incidence of splanchnic arterial involvement may be
much greater, in that lateral aortograms have not been
routinely obtained in evaluating these patients. The more
complete imaging in the present series revealed 62% to have
CA or SMA stenoses and occlusions, with both vessels
involved in 82% of these cases. Suprarenal or infrarenal
coarctations, when distant from the CA and SMA, are less
likely to be associated with stenotic branch disease, com-
pared to more centrally located abdominal aortic coarcta-
tions.
Clinical manifestations. Most patients, like those of
the current series, present with uncontrolled hypertension
due to suprarenal or intrarenal aortic coarctations, with
coexisting renal artery stenoses commonly associated with
developmental and inflammatory-related abdominal aortic
narrowings. Changes in pulsatile flow and pressure across
renal stenoses or aortic narrowings are responsible for
renin-angiotensin system activation and subsequent blood
pressure elevations. This form of renovascular hypertension
is usually resistant to simple pharmacologic control. An
occasional patient reports exercise-related lower extremity
fatigue, but true claudication is rare. Associated splanchnic
arterial occlusive disease affects a majority of those aortic
narrowings, yet symptomatic intestinal ischemia is very
uncommon. In the present series, more than half manifest
splanchnic occlusive lesions, yet only 6% experienced intes-
tinal angina.
Abdominal aortic coarctations usually cause signs or
symptoms during the first or second decade of life, yet an
earlier review noted that patients had reached a mean age of
22 years before the diagnosis was actually confirmed.8
Untreated, this entity has been associated with stroke,
progressive left ventricular hypertrophy with congestive
time in 92 renal and splanchnic revascularization
s with
ow-up
l
Overall
reconstructive
patency
Standard
error
[95% Confidence
intervals]
0.9771 0.0160 0.9117 0.9942
0.9771 0.0160 0.9117 0.9942
0.8780 0.0383 0.7780 0.9348
0.8780 0.0383 0.7780 0.9348
0.8312 0.0485 0.7095 0.9052
0.8312 0.0485 0.7095 0.9052
0.8312 0.0485 0.7095 0.9052
0.8312 0.0485 0.7095 0.9052
0.7619 0.0798 0.5606 0.8801
0.7619 0.0798 0.5606 0.8801
0.6531 0.1218 0.3661 0.8347
0.6531 0.1218 0.3661 0.8347
0.6531 0.1218 0.3661 0.8347
0.6531 0.1218 0.3661 0.8347
0.6531 0.1218 0.3661 0.8347ver
on
ction
te foll
terva
9
7
10
17
5
3
2
15
2
3
0
3
1
1heart failure and flash pulmonary edema, and less often with
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tients died at a mean age of 34 years.8
Pathogenesis. Many abdominal aortic coarctations
appear related to events occurring around day 25 of fetal
development. At that time the two embryonic dorsal aortas
fuse and lose their intervening wall to form a single vessel.
Overfusion of the two embryonic dorsal aortas or their
failure to fuse with subsequent obliteration of one of these
vessels would predictably result in an aortic narrowing.25
Developmental overfusion of the two primitive dorsal aor-
tas receives support in patients with decreased aortic diam-
eters who have single origins of the lumbar arteries.26 Such
a remarkable finding occurred frequently in our series (Fig
1, B).
Multiple renal arteries to one or both kidneys in nearly
half of the patients exhibiting suprarenal and intrarenal
abdominal aortic coarctations exceeds the 25 to 35% ob-
served in the general population and also supports a devel-
opmental etiology of these narrowings.8,16 Normal aortic
development occurs at approximately the same embryonic
time that the multiple metanephric arteries involute, leav-
ing a single renal artery. Dominance of this single renal
artery is alleged to result from its obligate hemodynamic
advantage over adjacent metanephric vessels. It is likely that
if aortic narrowings exist, flow disturbances will occur in the
vicinity of this principle renal artery and diminish its hemo-
dynamic advantage, allowing persistence of adjacent meta-
nephric channels. The fact that aortic narrowings distant
from the renal arteries are less likely to be associated with
multiple renal arteries lends further credence to this devel-
opmental hypothesis.8,16,24
Viral-mediated events may impede transition of fetal
mesenchymal tissue to vascular smooth muscle or alter its
organization and growth in utero, and also result in devel-
opmental aortic narrowings. Certain viruses, including ru-
bella, are cytocidal and inhibitory to cell replication, with
intimal fibroplasia and aortic hypoplasia as a consequence
being well recognized.27-29 In fact, fibroproliferative inti-
mal disorders have been documented in the aorta and large
elastic arteries of 16.5% of patients exhibiting the congen-
ital rubella syndrome.30
Patients with NF-1 exhibit an unusually high frequency
of arterial abnormalities, including developmental abdom-
inal aortic coarctations and renal artery stenoses.31 Because
of the protean nature of NF-1 and infrequent genetic
analyses of patients with abdominal aortic coarctation, the
exact frequency of this disease among these individuals is
unknown. Nevertheless, 29% of the current series’ patients
carried a diagnosis of NF-1. The primary vascular pathol-
ogy in neurofibromatosis appears to be related to abnormal
smooth muscle growth, not entrapment or invasion of the
arterial wall by neural elements.32,33 Similar events may
affect patients with the Alagille syndrome,34 and Williams’
syndrome.35 The authors have performed renal revascular-
izations in two additional Williams’ syndrome patients not
in the present series, who had earlier treatment of their
abdominal aortic coarctations performed elsewhere.Panaortitis with adventitial or periadventitial fibrosis
and associated inflammatory cell infiltrates, suggesting an
active or chronic aortitis, is another well recognized cause
of abdominal aortic coarctations. The proposition that
most abdominal aortic coarctations are a variant of an
inflammatory aortitis like Takayasu’s disease is quite con-
troversial and not supported by histological findings.20,36
This cause of aortic narrowings, suspected in only 8% of the
current series, is encountered much more often in the
subcontinent populations of Asia and South America.
Treatment options. The two procedures most com-
monly performed in treating aortic coarctations remain
open interventions. Patch aortoplasty, when technically fea-
sible has become the authors’ preferred means of treating
isolated abdominal aortic coarctations. In some cases, an
autologous arterial patch, especially for short coarctations,
may be appropriate.37 Thoracoabdominal bypass may be
favored in certain patients having too small of a coarctation
segment to allow placement of a patch or in cases of
complex disease affecting the renal and splanchnic arteries.
Reoperations are infrequent, but may be required for
anastomotic narrowings or if a patient outgrows the ade-
quacy of the primary procedure. The fact that nearly 10% of
the currently reported cases required late secondary opera-
tions supports the importance of life-long follow-up of
these patients. Aneurysmal aortic deterioration in the re-
gion of a patch in one of our patients, many years after the
initial reconstruction and 2 years after she completed her
only pregnancy, deserves note. The effect of gestational
hormones and blood pressure increases during pregnancy
may be relevant, in that pregnancy-related aortic diameter
increases of 1.5 cm or more have been observed at the site
of thoracic aortic coarctation repairs in nearly 10% of those
undergoing such an intevervention.38 Although this find-
ing may not be directly extrapolated to abdominal aortic
coarctation repairs, it does justify close surveillance of those
patients who subsequently become pregnant.
Simultaneous or staged aortic and visceral artery recon-
structions depend on the clinical relevance of the nonaortic
disease as well as the proximity of the aortic reconstruction
to the affected aortic branches. Certainly, renal artery ste-
noses and secondary renovascular hypertension justify an
aggressive reconstructive approach. A mandate to recon-
struct the CA or SMA applies only to symptomatic cases.
Nevertheless, a relative indication to prophylactically re-
construct these vessels exists when performance of an aor-
toplasty or renal revascularization would make a subse-
quent CA or SMA revascularization exceedingly difficult.
When the aortic reconstruction was distant from the CA or
SMA, such as with thoracoabdominal bypass, a concomi-
tant splanchnic revascularization is less likely to be per-
formed.
Treatment of select abdominal aortic coarctations may
involve endoluminal stenting. Although endovascular ther-
apy for thoracic aortic coarctation has resulted in a higher
incidence of restenosis and secondary procedures than open
surgery,39 a technical success rate exceeding 97% and peri-
procedural mortality of 0.4% associated with stenting native
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an appealing option for treating abdominal coarctations.40
Current endovascular technologies appear to allow the safe
treatment of focal stenoses remote from the CA, SMA, and
renal arteries. Percutaneous transluminal angioplasty of an
abdominal aortic coarctation was first reported in 1983.13
Subsequent case reports described the transition in the use
of stents in these cases.1,6,13 In fact, early and late failures of
balloon angioplasty alone suggest that stent placement is
necessary to overcome the significant recoil of these often
hypoplastic and highly fibrotic aortic narrowings.7,10,17,41
The authors remain cautious at accepting the long-
term benefits of endoluminal treatment of abdominal aortic
coarctation in any patient, except adults with very focal
narrowings distant from their renal arteries. Given the high
frequency with which the renal and splanchnic arteries are
affected in abdominal aortic coarctation, especially in the
younger-growing patient, the number of lesions amenable
to endovascular repair is likely to be limited.
Long-term follow-up of patients undergoing surgical
treatment of their abdominal aortic coarctation is war-
ranted. No patient in the present experience has developed
an unacceptable failure of their aortic reconstruction.How-
ever, follow-up in this series has been relatively brief and has
involved a generally younger group of patients with long
life expectancies. Annual noninvasive assessments of lower
extremity blood flow with exercise ankle-brachial indices
are recommended. Imaging with MRA studies or CTA
should be obtained if any evidence of diminished blood
flow exists. Similar imaging is appropriate if blood pressure
increases occur in those who have undergone concomitant
renal artery reconstructions or whose renal blood flow is
dependent upon their aortic reconstruction.
The authors appreciate contributions to this work from
those referring physicians from Pittsburgh, Pa, Philadelphia,
Pa, and Sioux Falls, SD, whose patients’ preoperative im-
ages (Figs 1, 4, A and 5, A) are included in this publication.
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